Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Kokubyo Gakkai Zasshi. the Journal of the Stomatological Society, Japan|May 20, 1999
[Studies on generation of cytotoxic T lymphocytes against oral squamous carcinoma by gene-transduction of a co-stimulatory molecule, CD80]S Mogi
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|September 1, 1996
[Caregiver burden and subjective health level in primary caregivers of stroke patients]S Usuda, S Mogi, A Tomita, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 16, 2006
Cyclin B1 is useful to predict occult cervical lymph node metastases in tongue carcinomaH Harada, K Omura, Y Nakajima, et al.
Microbiology and Immunology|January 1, 1987
A novel enzyme immunoassay commonly applied for ten strains of Pyricularia oryzaeT Kitagawa, W Ohtani, H Tanimori, et al.
The American Journal of Pathology|January 1, 1993
Immunohistochemical analysis of keratin distribution in eccrine poromaS Watanabe, S Mogi, E Ichikawa, et al.
Bioscience, Biotechnology, and Biochemistry|March 1, 1993
A neopullulanase-type alpha-amylase gene from Thermoactinomyces vulgaris R-47T Tonozuka, M Ohtsuka, S Mogi, et al.
Immunology|December 21, 2000
Tumour rejection by gene transfer of 4-1BB ligand into a CD80(+) murine squamous cell carcinoma and the requirements of co-stimulatory molecules on tumour and host cellsS Mogi, J Sakurai, T Kohsaka, et al.
European Journal of Immunology|July 24, 2001
Rapid induction of CD95 ligand and CD4+ T cell-mediated apoptosis by CD137 (4-1BB) costimulationT Ebata, S Mogi, Y Hata, et al.
Biochimica Et Biophysica Acta|September 27, 1995
Comparison of primary structures and substrate specificities of two pullulan-hydrolyzing alpha-amylases, TVA I and TVA II, from Thermoactinomyces vulgaris R-47T Tonozuka, S Mogi, Y Shimura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2S Mogi, T Ebata, Y Setoguchi, et al.
Pageof 2